Command Palette

Search for a command to run...

ishita-drugs-&-industries

74.63+0.00%
Market Cap
₹0.00 Cr
Stock P/E
0.00
ROCE
0.00%
ROE
0.00%
Book Value
₹0.00

You might have missed

No Recent News

No recent news available for this stock.

Shareholding

Holdings
Distribution
Promoter
Public
Others

From Last Concall

No Concall Summary

Conference call summary is not available for this stock.

Peers Summary

Sector Leader

In the Pharmaceuticals & Drugs sector, Ishita Drugs & Industries Ltd. stands out for its unique position with no revenue or profit metrics reported, contrasting sharply with its peers who demonstrate varying degrees of financial performance and valuation. While some companies showcase strong profitability and growth, Ishita appears financially weak, suggesting a potential risk for investors. Companies like Sun Pharmaceutical and Dr. Reddy's display strong performance metrics, indicating they are sector leaders, while Ishita may need to improve its financial health to remain competitive.

Key Points
  • Ishita Drugs has no reported revenue or profitability metrics.
  • Sun Pharmaceutical and Dr. Reddy's are leaders with strong growth and profitability.
  • Ishita Drugs is a financial outlier with no growth or profit, raising risk concerns.
Top Performers
Sun Pharmaceutical Industries Ltd.

Highest revenue growth of 8.42% YoY, strong EPS growth, and ROE of 16.13%.

Dr. Reddy's Laboratories Ltd.

High profitability with a PE ratio of 15.50 and strong growth metrics.

Leveling the playing field in markets.

© 2025 EQHQ Technologies Pvt Ltd

"Information provided is for educational purposes only and not financial advice.